Standard
164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study. / Sethi, AA; Tybjærg-Hansen, A; Jensen, Gorm Boje; Nordestgaard, BG; Tybjærg-Hansen, Anne; Nordestgaard, Børge G.
I:
Pharmacogenetics and Genomics, Bind 15, Nr. 9, 2005, s. 633-45.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Sethi, AA, Tybjærg-Hansen, A, Jensen, GB, Nordestgaard, BG
, Tybjærg-Hansen, A & Nordestgaard, BG 2005, '
164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study',
Pharmacogenetics and Genomics, bind 15, nr. 9, s. 633-45. <
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16041242&query_hl=1&itool=pubmed_docsum>
APA
Sethi, AA., Tybjærg-Hansen, A., Jensen, G. B., Nordestgaard, BG.
, Tybjærg-Hansen, A., & Nordestgaard, B. G. (2005).
164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study.
Pharmacogenetics and Genomics,
15(9), 633-45.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16041242&query_hl=1&itool=pubmed_docsumVancouver
Sethi AA, Tybjærg-Hansen A, Jensen GB, Nordestgaard BG, Tybjærg-Hansen A, Nordestgaard BG. 164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study. Pharmacogenetics and Genomics. 2005;15(9):633-45.
Author
Sethi, AA ; Tybjærg-Hansen, A ; Jensen, Gorm Boje ; Nordestgaard, BG ; Tybjærg-Hansen, Anne ; Nordestgaard, Børge G. / 164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study. I: Pharmacogenetics and Genomics. 2005 ; Bind 15, Nr. 9. s. 633-45.
Bibtex
@article{e0af73f94e8941b48248d7a5ad7146a4,
title = "164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study",
abstract = "Since beta2-adrenergic receptors are important regulators of blood pressure, genetic variation in this receptor could explain risk of elevated blood pressure in selected individuals. We tested the hypothesis that Gly16Arg, Gln27Glu, and Thr164Ile in the beta2-adrenergic receptor gene associated with elevated blood pressure.",
author = "AA Sethi and A Tybj{\ae}rg-Hansen and Jensen, {Gorm Boje} and BG Nordestgaard and Anne Tybj{\ae}rg-Hansen and Nordestgaard, {B{\o}rge G.}",
year = "2005",
language = "English",
volume = "15",
pages = "633--45",
journal = "Pharmacogenetics",
issn = "1744-6872",
publisher = "Lippincott Williams & Wilkins",
number = "9",
}
RIS
TY - JOUR
T1 - 164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study
AU - Sethi, AA
AU - Tybjærg-Hansen, A
AU - Jensen, Gorm Boje
AU - Nordestgaard, BG
AU - Tybjærg-Hansen, Anne
AU - Nordestgaard, Børge G.
PY - 2005
Y1 - 2005
N2 - Since beta2-adrenergic receptors are important regulators of blood pressure, genetic variation in this receptor could explain risk of elevated blood pressure in selected individuals. We tested the hypothesis that Gly16Arg, Gln27Glu, and Thr164Ile in the beta2-adrenergic receptor gene associated with elevated blood pressure.
AB - Since beta2-adrenergic receptors are important regulators of blood pressure, genetic variation in this receptor could explain risk of elevated blood pressure in selected individuals. We tested the hypothesis that Gly16Arg, Gln27Glu, and Thr164Ile in the beta2-adrenergic receptor gene associated with elevated blood pressure.
M3 - Journal article
VL - 15
SP - 633
EP - 645
JO - Pharmacogenetics
JF - Pharmacogenetics
SN - 1744-6872
IS - 9
ER -
